Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shz 1 is a cardiogenic agent that induces phenotypic differentiation and various cardiac-specific genes including sarcomeric tropomyosin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 33.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 289.00 | |
50 mg | In stock | $ 455.00 | |
100 mg | In stock | $ 672.00 | |
500 mg | In stock | $ 1,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | Shz 1 is a cardiogenic agent that induces phenotypic differentiation and various cardiac-specific genes including sarcomeric tropomyosin. |
In vitro | Shz-1 showes a ~1.5-fold increase in cardiac transcripts of the Nkx2.5 gene. Shz-1 augments the expression of transcripts of the total sarcomeric TPM1 (both TPM1α & TPM1κ) and sarcomeric TPM4α. Shz-1 activates the axolotl TPM4 promoter-driven ectopic expression in C2C12 cells[1]. |
Molecular Weight | 355.21 |
Formula | C13H11BrN2O3S |
CAS No. | 326886-05-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.8 mg/mL (13.51 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Shz 1 326886-05-9 Others sarcomeric tropomyosin inhibit cardiac-specific Shz1 Inhibitor Nkx2.5 expression cardiogenic molecule Shz-1 inhibitor